51) Miyasaka EA, Brown PI, Kadoura S, et al The adolescent child with short bowel syndrome: new
onset of failure to thrive and need for increased nutritional supplementation. J Pediatr Surg. 2010; 45:
1280-6.
52) Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutritiondependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124: 293-02
53) Peretti N, Loras-Duclaux I, Kassai B, et al. Growth hormone to improve short bowel syndrome
intestinal autonomy: a pediatric randomized open-label clinical trial. J Parenter Enteral Nutr 2011; 35:
723-31.
54) Yang H, Teitelbaum DH. Novel agents in the treatment of intestinal failure: humoral factors.
Gastroenterology 2006; 130(2 Suppl 1): S117-21
55) Goulet O, Dabbas-Tyan M, Talbotec C, et al. Effect of recombinant human growth hormone on
intestinal absorption and body composition in children with short bowel syndrome. J Parenter Enteral
Nutr 2010; 34: 513-20
56) Wales PW, Nasr A, de Silva N, et al. Human growth hormone and glutamine for patients with short
bowel syndrome. Cochrane Database Syst Rev 2010;(6): CD006321.
57) Wallis K, Walters JR, Gabe S. Short bowel syndrome: the role of GLP-2 on improving outcome. Curr
Opin Clin Nutr Metab Care 2009; 12: 526-32
58) Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in
reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel
syndrome. Gut 2011; 60: 902-14
59) Hamer HM, Jonkers DM, Bast A, et al. Butyrate modulates oxidative stress in the colonic mucosa of
healthy humans. Clin Nutr 2009; 28: 88-93
60) McMellen ME, Wakeman D, Longshore SW, et al. Growth factors: possible roles for clinical
management of the short bowel syndrome. Semin Pediatr Surg 2010; 19: 35-43
61) Bianchi A. Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr
Surg 1980; 15: 145-51
62) Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case
report. J Pediatr Surg 2003; 38: 881-885
63) Bianchi A. Intestinal lengthening: an experimental and clinical review. J R Soc Med 1984; 77(Suppl
3): 35-41
64) Sudan D, Thompson J, Botha J, et al. Comparison of intestinal lengthening procedures for patients
with short bowel syndrome. Ann Surg 2007; 246: 593-601
65) Khalil BA, Ba'ath ME, Aziz A, et al. Intestinal Rehabilitation And Bowel Reconstructive Surgery:
Improved Outcomes In Children With Short Bowel Syndrome. J Pediatr Gastroenterol Nutr 2011 [Epub
ahead of print]
66) Goulet O, Philips AD. In: Walker’s Pediatric Gastrointestinal Disease, 5th edition. BC DeckerInc; Page:
309-316
67) Berni Canani R, Terrin G, Cardillo G, et al. Congenital diarrheal disorders: improved understanding
of gene defects is leading to advances in intestinal physiology and clinical management. J Pediatr
Gastroenterol Nutr 2010; 50: 360-6.
68) Ruemmele FM, Jan D, Lacaille F, et al. New perspectives for children with microvillous inclusion
disease: early small bowel transplantation. Transplantation 2004; 77: 1024-8.
69) Halac U, Lacaille F, Joly F, et al. Microvillous inclusion disease: how to improve the prognosis of a
severe congenital enterocyte disorder. J Pediatr Gastroenterol Nutr 2011; 52: 460-5.
70) Sivagnanam M, Mueller JL, Lee H, et al. Identification of EpCAM as the gene for congenital tufting
enteropathy. Gastroenterology 2008; 135: 429-437.
71) Salomon J, Espinosa-Parrilla Y, Goulet O, et al. A founder effect at the EPCAM locus in Congenital
Tufting Enteropathy in the Arabic Gulf. Eur J Med Genet 2011; 54: 319-22.
72) Lemale J, Coulomb A, Dubern B, et al. Intractable diarrhea with tufting enteropathy: a favorable
outcome is possible. J Pediatr Gastroenterol Nutr 2011; 52: 734-9
73) Goulet O, Salomon J, Ruemmele F, et al. Intestinal epithelial dysplasia (tufting enteropathy).
Orphanet J Rare Dis 2007; 2: 20
74) Heinz-Erian P, Müller T, Krabichler B, et al. Mutations in SPINT2 cause a syndromic form of
congenital sodium diarrhea. Am J Hum Genet 2009; 84: 188-96.
75) Salomon J, Canioni D, Lemale J, et al. Genotype-phenotype correlation and immunohistopathology
characterization of 38 cases of congenital tuftingenteropathy (CTE). J Pediatr Gastroenterol Nutr 2011;
52(suppl 2): E119
76) Goulet O, Vinson C, Roquelaure B, et al. Syndromic (phenotypic) diarrhea in early infancy. Orphanet
J Rare Dis 2008; 3: 6.
77) Fabre A, Martinez-Vinson C, Roquelaure B, et al. Novel mutations in TTC37 associated with trichohepato-enteric syndrome. Hum Mutat 2011; 32: 277-81.
78) Fabre A, Charroux B, Martinez-Vinson C, et al. SKIV2L mutations cause syndromic diarrhea, or
trichohepatoenteric syndrome. Am J Hum Genet 2012; 90: 689-92.
79) Goulet OJ, Brousse N, Canioni D, et al. Syndrome of intractable diarrhoea with persistent villous
atrophy in early childhood: a clinicopathological survey of 47 cases. J Pediatr Gastroenterol Nutr 1998;
26: 151-161.
80) Pakarinen MP, Koivusalo AI, Rintala RJ. Outcomes of intestinal failure – a comparison between
children with short bowel and dysmotile intestine. J Pediatr Surg 2009; 44: 2139-44
81) Srinathan SK, Langer JC, Blennerhassett MG, et al. Etiology of intestinal damage in gastroschisis. III:
morphometric analysis of the smooth muscle and submucosa. J Pediatr Surg 1995; 25: 1122-6.
82) Goulet O, Sauvat F, Jan D. Surgery for pediatric patients with chronic intestinal pseudo-obstruction
syndrome. J Pediatr Gastroenterol Nutr 2005; 41(Suppl 1): S66-8.
83) Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudoobstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997;24: 102-12.
84) Lapointe SP, Rivet C, Goulet O, et al. Urological manifestations associated with chronic intestinal
pseudo-obstructions in children. J Urol 2002; 168: 1768-70.
85) Di Lorenzo C, Youssef NN. Diagnosis and management of intestinal motility disorders. Sem Pediatr
Surg 2010; 19: 50-58
86) Galmiche L, Jaubert F, Sauvat F, et al. Normal oxidative phosphorylation in intestinal smooth muscle
of childhood chronic intestinal pseudo-obstruction. Neurogastroenterol Motil 2011; 23: 24-9.
87) Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying
scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society
of Nuclear Medicine. Am J Gastroenterol 2008; 103: 753-63.
88) Lapointe R. Chronic idiopathic intestinal pseudo-obstruction treated by near total small bowel
resection: a 20-year experience. J Gastrointest Surg 2010;14 : 1937-42
89) Goulet O, Talbotec C, Jan D, et al. Nutritional management of pediatric patients with chronic
intestinal pseudo-obstruction syndrome. J Pediatr Gastroenterol Nutr 2001; 32(Suppl 1): S44-7
90) Di Lorenzo C, Lucanto C, Flores AF, et al. Effect of sequential erythromycin and octreotide on
antroduodenal manometry. J Pediatr Gastroenterol Nutr 1999; 29: 293-6.
91) Gmora S, Poenaru D, Tsai E. Neostigmine for the treatment of pediatric acute colonic pseudoobstruction. J Pediatr Surg 2002; 37: E28.
92) Faure C, Goulet O, Ategbo S, et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis,
outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis
Sci 1999; 44: 953-9.
93) De Giorgio R, Cogliandro RF, Barbara G, et al. Chronic intestinal pseudo-obstruction: clinical
features, diagnosis, and therapy. Gastroenterol Clin North Am 2011; 40: 787-807.
94) Greenberg RG, Moran C, Ulshen M, et al. Outcomes of catheter-associated infections in pediatric
patients with short bowel syndrome. J Pediatr Gastroenterol Nutr 2010; 50: 460-2.
95) Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use of
a central venous line bundle: Epidemiologic and economic consequences. Am J Infect Control 2011; 39:
640-6
96) Miller SJ. Bloodstream Infections Associated With Parenteral Nutrition Preparation Methods in the
United States: A Retrospective, Large Database Analysis. J Parenter Enteral Nutr 2011. Sep 30. [Epub
ahead of print]
97) Norman JL, Crill CM. Optimizing the transition to home parenteral nutrition in pediatric patients.
Nutr Clin Pract 2011; 26: 273-85
98) Wales PW, Kosar C, Carricato M, et al. Ethanol lock therapy to reduce the incidence of catheterrelated bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary
experience. J Pediatr Surg 2011; 46: 951-6
99) Koletzko B, Goulet O, Hunt J, et al. Guidelines on Paediatric Parenteral Nutrition of the European
Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society
for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric
Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41(Suppl 2): S1-S87.
100) Pittiruti M, Hamilton H, Biffi R, et al. ESPEN Guidelines on Parenteral Nutrition: Central Venous
Catheters (access, care, diagnosis and therapy of complications). Clinical Nutr 2009; 28: 365-377
101) Goulet O, Joly F, Corriol O, et al. Some new insights in intestinal failure-associated liver disease.
CurrOpin Organ Transplant 2009; 14: 256-261.
102) Kurvinen A, Nissinen M, Gylling H, et al. Effects of Long-term Parenteral Nutrition on Serum Lipids,
Plant Sterols, Cholesterol Metabolism, and Liver Histology in Pediatric Intestinal Failure. J Pediatr
Gastroenterol Nutr 2011; 53: 440-446
103) Hermans D, Talbotec C, Lacaille F, et al. Early central catheter infections may contribute to hepatic
fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007; 44: 45963.
104) Willis TC, Carter BA, Rogers SP, et al. High rates of mortality and morbidity occur in infants with
parenteral nutrition-associated cholestasis. J Parenter Enteral Nutr 2010; 34: 32-37.
105) Robinson DT, Ehrenkranz RA. Parenteral nutrition-associated cholestasis in small for gestational
age infants. J Pediatr 2008; 152: 59-62.
106) Hsieh MH, Pai W, Tseng HI, et al. Parenteral nutrition-associated cholestasis in premature babies:
risk factors and predictors. Pediatr Neonatol 2009; 50: 202-207.
107) Roma MG, Sanchez Pozzi EJ. Oxidative stress: a radical way to stop making bile. Ann Hepatol 2008;
7: 16-33.
108) Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients
receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132: 52532.
109) Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with
long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000; 24: 345-350.
110) Ganousse S, C Talbotec, P de Villartay, et al. Assessment and outcome of patients with protracted
intestinal failure referred for intestinal transplantation. Proceeding of the X small bowel transplantation
symposium, september 5-8 2007, Santa Monica California.
111) Koletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutritionassociated cholestatic liver disease. Curr Opin Clin Nutr Metab Care 2010; 13: 321-6.
112) Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition- associated liver disease in
two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Pediatrics 2006; 118: e197-e201.
113) Linseisen J, Hoffmann J, Lienhard S, et al. Antioxidant status of surgical patients receiving TPN with
an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000;
19: 177-184.
114) Wanten G, Beunk J, Naber A, et al. Tocopherol isoforms in parenteral lipid emulsions and
neutrophil activation. Clin Nutr 2002; 21: 417-22.
115) Mertes N, Grimm H, Furst P, et al. Safety and efficacy of a new parenteral lipid emulsion
(SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006;
50: 253-259.
116) Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition
associated cholestatic liver disease. Gastroenterology 1993; 105: 1806-1813.
117) Forchielli ML, Bersani G, Tala S, et al. The spectrum of plant and animal sterols in different oilderived intravenous emulsions. Lipids 2010; 45: 63-71.
118) Bindl L, Lutjohann D, Buderus S, et al. High plasma levels of phytosterols in patients on parenteral
nutrition: a marker of liver dysfunction. J Pediatr Gastroenterol Nutr 2000; 31: 313-316.
119) Clayton PT, Whitfield P, Lyer K. The role of phytosterols in the pathogenesis of liver complications
of pediatric parenteral nutrition. Nutrition 1998; 14: 158-164.
120) Linseisen J, Hoffmann J, Lienhard S, et al. Antioxidant status of surgical patients receiving TPN with
an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000;
19: 177-184.
121) Socha P, Koletzko B, Pawlowska J, et al. Treatment of cholestatic children with water-soluble
vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides,
and polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 1997; 24: 189-193.
122) Tomsits E, Tolgysi A, Fekete G, et al. Safety and efficacy of a lipid emulsion containing a mixture of
soybean, olive, coconut and fish oils: a randomized double blind trial in premature infants requiring
parenteral nutrition. J Pediatr Gastroenterol Nutr 2010; 51: 514-21.
123) Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing fish oil: a single
center, double-blind randomized study on long-term efficacy and safety in pediatric patients. J Parenter
Enteral Nutr 2010; 34: 485-95.
124) Muhammed R, Bremner R, Protheroe, et al. Resolution of Parenteral Nutrition-associated Jaundice
on Changing From a Soybean Oil Emulsion to a Complex Mixed-Lipid Emulsion. J Pediatr Gastroenterol
Nutr 2012; 54(6):797-802
125) de Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty
acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010; 50: 212-8
126) Sudan D, Dibaise J, Torres C, et al. A multidisciplinary approach to the treatment of intestinal
failure. J Gastrointest Surg 2005; 9: 165-176
127) Modi BP, Langer M, Ching YA, et al. Improved survival in a multidisciplinary short bowel syndrome
program. J Pediatr Surg 2008; 43: 20-4
128) Beath S, Pironi L, Gabe S, et al. Collaborative strategies to reduce mortality and morbidity in
patients with chronic intestinal failure including those who are referred for small bowel
transplantation. Transplantation 2008; 85: 1378-84.
129) Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361: 998-1008.
130) Grant D. On behalf of the Intestine Transplant Registry. 2011 preliminary report of the Intestine
Transplant Registry. Presentation at the XII International Small Bowel Transplant Symposium, 15-18
September 2011, Washington DC, USA.
131) Pironi L, Forbes A, Joly F, et al. Survival of patients identified as candidates for intestinal
transplantation: a 3-year prospective follow-up. Gastroenterology 2008;135:61e71.
132) Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for paediatric intestinal transplantation: a
position paper of the American Society of Transplantation. Pediatr Transplantation 2001;5:80e7.
133) Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations
at a single center: major advances with new challenges. Ann Surg 2009; 250: 567-81
134) Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in
Europe: implications for intestinal transplantation. Gut 2011; 60: 17-25
135) Colomb V, Dabbas-Tyan M, et al. Long-term outcome of children receiving home parenteral
nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr 2007; 44:
347-53.
136) Sauvat F, Fusaro F, Lacaille F, et al. Is intestinal transplantation the future of children with
definitive intestinal insufficiency? Eur J Pediatr Surg 2008; 18: 368-71.